NDAC’s Wood To Join Private Rx Investment Firm
This article was originally published in The Pink Sheet Daily
Executive Summary
Nonprescription Drugs Advisory Committee Chair Alastair Wood will join Symphony Capital, which specializes in biopharmaceutical investments.